Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Read more about Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation Read more about Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Read more about TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma Read more about Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
Surveillance AFter Extremity Tumor surgerY Read more about Surveillance AFter Extremity Tumor surgerY
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3) Read more about First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer Read more about A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Read more about Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF Read more about Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF